Dr. Julie Ann Moore, DMD Dentist Medicare: Medicare Enrolled Practice Location: 4351 Commercial Way, Springhill, FL 34606 Phone: 352-597-4977 Fax: 352-597-9263 |
News Archive
AARP called on Congress today to give the Food and Drug Administration (FDA) the authority to approve safe, cost-effective generic versions of often expensive biologic drug therapies.
This research, conducted at the University of Granada, also reveals that soy protein supplements are better than those with whey, since they improve calcium content in bones by as much as seven per cent. This research has been published in the journal Food & Function
A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.
NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology devices, today announced it has been awarded a grant of approximately $250,000 from the Qualifying Therapeutic Discovery Project (QTDP) Program. The QTDP's grants and tax credits are provided under the new section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
› Verified 1 days ago